Back to Search Start Over

Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC

Authors :
Kathryn C. Arbour
Nikolaus Schultz
Matthew D. Hellmann
Andrew J. Plodkowski
Walid K. Chatila
Megan Tenet
Marc Ladanyi
Francisco Sanchez-Vega
Hira Rizvi
Jamie E. Chaft
Darragh Halpenny
Jennifer L. Sauter
Niamh Long
Source :
Journal of Clinical Oncology. 36:9022-9022
Publication Year :
2018
Publisher :
American Society of Clinical Oncology (ASCO), 2018.

Abstract

9022Background: The transcendent feature of response to anti-PD-(L)1 therapy is durable, long-term responses, which can last up to years. Much effort in biomarkers has focused exclusively on initia...

Details

ISSN :
15277755 and 0732183X
Volume :
36
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........5fdca4ab78d797c7f3c0677d32e8014d
Full Text :
https://doi.org/10.1200/jco.2018.36.15_suppl.9022